Author Archives: Lisa

About Lisa

I have been a Clinical Informationist (aka Medical Librarian) for Emory University since September 2013. Prior to that, I was a Medical Librarian for Lincoln Memorial University (LMU) from March 2007 to August 2013 and served its DeBusk College of Osteopathic Medicine, Caylor School of Nursing, and allied health programs. From January 2002 - March 2007, I served the Medical Assisting (MA), Occupational Therapy Assistant, Physical Therapy Assistant, Radiologic Technologist, and Nursing programs at South College in Knoxville, Tennessee. I graduated from The University of Tennessee School of Information Sciences with a Master of Science degree in December 2000.

EUH Morning Report: In patients with acute alcoholic hepatitis, does steroid therapy increase the risk of GI bleeding compared to no use of steroids?

The Bottom Line: For patients with acute alcoholic hepatitis, there isn’t literature to answer the question of whether steroid therapy increases risk of GI bleeding compared to no use of steroids. For patients with non-acute alcoholic liver disease who do not have concomitant … Continue reading

Posted in Applying evidence, EUH, Therapy | Tagged

EUH Krakow Conference: Does empagliflozin cause ketoacidosis?

Bottom Line: An analysis of FDA Adverse Event Reporting System (FAERS) data and three case reports provide evidence that sodium glucose cotransporter 2 (SGLT2) inhibitors (canagliflozin, dapagliflozin, and empagliflozin) cause ketoacidosis. FAERS data A search was done of the FAERS data … Continue reading

Posted in EUH, Therapy

EUH Krakow Conference: What are all of the causes of anion gap acidosis and are there mnemonics by which to remember them?

Bottom Line: Causes of anion gap metabolic acidosis are broken down into the following categories: overproduction of acid due to ketoacidosis or lactic acidosis, underexcretion of acid (such as due to advanced renal failure/chronic kidney disease (uremia)), cell lysis (such … Continue reading

Posted in Background question, EUH

EUH Resident Report: Map showing North American distributions of four fungal lung diseases

See page 90 for a map showing the North America distributions of histoplasma, blastomyces, coccidioides, and Cryptococcus gattii (c. gattii). Source: Hage CA. Fungal lung disease. In: Schraufnagel DE, ed. Breathing in America: Diseases, Progress, and Hope. American Thoracic Society (ATS); 2010:89-97.

Posted in Background question

EUH Resident Report: In arterial thromboembolic events, what percentage have cardiogenic sources versus other sources?

Bottom line: Three studies have attributed arterial thromboembolic events to cardiogenic sources in 33%, 51%, and 66% of cases. Studies of larger populations are needed. Sources: Mural thrombus of the aorta: an important, frequently neglected cause of large peripheral emboli. … Continue reading

Posted in Diagnosis, EUH | Tagged

EUH Resident Report: What are indications for anticoagulants for primary prevention of left ventricular thrombosis?

Bottom line: Indications for anticoagulants for primary prevention of left ventricular thrombosis include patients with the following traits: large anterior infarctions (particularly in the anterior location), heart failure, and high embolic risk (including those with echocardiographic evidence of mobile and … Continue reading

Posted in Applying evidence, Background question, EUH | Tagged

EUH Resident Report: Vitamin k administration routes for prevention of thrombosis

Bottom line: Evidence that is of low and moderate quality, respectively, is used in a guideline that recommends against routine vitamin K supplementation for patients taking vitamin K antagonists (VKAs) (grade 2c) and against routine vitamin K supplementation for patients taking VKAs … Continue reading

Posted in EUH, Therapy | Tagged